#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Burkitt's lymphoma Necrotising myositis Duchenne muscular dystrophy gene carrier Short stature Medulloblastoma recurrent Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Meningitis meningococcal Acute lymphocytic leukaemia Hyperinsulinism Proteus syndrome Hypomagnesaemia Myxofibrosarcoma Congenital disorder of glycosylation Astrocytoma Deafness bilateral More trials…

    Learn about Rare Diseases

    Langerhans cell sarcoma – Basic Information Hereditary angioedema with C1 esterase inhibitor deficiency Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Loeys-Dietz syndrome – Diagnostics Cerebral arteriovenous malformation haemorrhagic – Basic Information MELAS syndrome – Basic Information Proteus syndrome – Basic Information Leiomyosarcoma recurrent – Life with Disease Splenic marginal zone lymphoma – Trials in Disease Mantle cell lymphoma refractory – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gilteritinib Citric Acid Monohydrate Rosnilimab Sodium Acetate Trihydrate 68Ganota-Anti-Her2 Vhh1 Cilazapril Baxdrostat Encorafenib Mosunetuzumab SURVODUTIDE Danazol Oleclumab Deutivacaftor Gelatin Oxytocin Synthetic Ociperlimab Antithrombin Iii Human Caspofungin Acetate Ly4100511 Pegcetacoplan More therapies…

    Learn about Your Condition

    Retinal vein occlusion Hyponatraemia Small fibre neuropathy Uterine cancer MELAS syndrome Soft tissue sarcoma Biliary adenoma Hepatic fibrosis COVID-19 Tooth loss Peripheral spondyloarthritis Anal cancer recurrent Shock Colitis Epstein-Barr virus infection More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Alpelisib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Alpelisib
    Croatia

  • Study on Propranolol for Preventing PTSD in Women After Sexual Violence

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Propranolol
    France

  • Study of Fecal Microbiota Capsules for Treating Non-Alcoholic Steatohepatitis in Patients

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Spain

  • Study Comparing Laser Treatment and Tafluprost Eye Drops for Patients with Exfoliation Glaucoma or Ocular Hypertension

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Tafluprost
    Finland

  • Study on Eplerenone for Heart Health in Kidney Transplant Patients Using Cyclosporine or Tacrolimus

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Renal transplant
    Investigated Drugs:
    • Eplerenone
    France

  • Study on Sirolimus and Prednisolone for Treating Superficial Arteriovenous Malformations in Patients

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Congenital arterial malformation
    Investigated Drugs:
    • Prednisolone Metasulfobenzoate Sodium
    • Sirolimus
    France
Previous Page
1 … 831 832 833 834 835 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!